Design Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -8.33M
Depreciation and Depletion 0.01M0.13M0.41M0.54M0.60M
Share-based Compensation 0.45M4.69M10.93M13.09M13.07M
Gains from Investment Securities 1.72M0.80M4.00M0.70M0.10M
Non-cash Items 8.47M
Cash from Operations -8.67M-29.38M-51.32M-58.56M-43.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.07M0.08M1.40M6.08M6.20M
Amortization of Deferred Charges 0.01M
Depreciation & Amortization (CF) 0.01M0.13M0.41M0.54M0.60M
Change in Working Capital
Change in Accured Expenses 1.43M2.42M5.40M-1.25M-1.22M
Investing Activities
Capital Expenditures 0.08M1.54M0.92M0.26M0.34M
Sales of Property, Plant and Equipment 0.04M
Change in Acquisitions & Divestments 22.10M34.16M92.89M277.50M274.47M
Cash from Investing Activities -33.56M-53.64M-220.99M52.54M43.95M
Financing Activities
Other financing activities 0.43M
Change in Capital Stock
Shares Issued 0.00M254.27M0.32M0.42M0.04M
Preferred Shares Issued 44.73M124.71M
Misc.
Cash from Financing Activities 44.53M379.21M0.23M0.72M0.51M
Change in Cash 2.30M296.19M-272.07M-5.30M1.36M
Free Cash Flow -8.74M-30.91M-52.23M-58.82M-43.45M
Net Cash Flow 2.30M296.19M-272.07M-5.30M1.36M